Jeremy Grantham's EXAS Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 217,755 shares of Exact Sciences Corporation (EXAS) worth $22.12 M, representing 0.06% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jeremy Grantham has initiated a new position in EXAS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +217,755 | New Buy | 217,755 | $101.56 |
Jeremy Grantham's Exact Sciences Corporation Investment FAQs
Jeremy Grantham first purchased Exact Sciences Corporation (EXAS) in Q4 2025, acquiring 217,755 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Exact Sciences Corporation (EXAS) for 1 quarters since Q4 2025.
Jeremy Grantham's largest addition to Exact Sciences Corporation (EXAS) was in Q4 2025, adding 217,755 shares worth $22.12 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 217,755 shares of Exact Sciences Corporation (EXAS), valued at approximately $22.12 M.
As of the Q4 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.06% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Exact Sciences Corporation (EXAS) was 217,755 shares, as reported at the end of Q4 2025.